Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04978779
Title A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vincerx Pharma, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL

Facility Status City State Zip Country Details
University of Cincinnati Medical Center Cincinnati Ohio 45219 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
Pratia MCM Krakow Kraków 30-510 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field